This inventor holds 2 USPTO granted patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2003-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2008
Title: Nena Winand: Innovator in Cancer Research
Introduction
Nena Winand is a prominent inventor based in Freeville, NY (US), known for her significant contributions to cancer research. With a total of 2 patents, she has made remarkable strides in understanding genetic factors that influence cancer predisposition.
Latest Patents
One of her latest patents is a method for detecting alterations in the MSH5 gene. This discovery reveals that mammals possess a DNA gene analogous to one found in bacteria. MSH5 defects or alterations in this mismatch repair pathway can serve as diagnostic indicators of a predisposition to cancer and provide prognostic information for specific types of cancer. Winand and her team have sequenced MSH5 in various mammals, including humans. This gene has potential applications in assays, gene product expression, drug screening, and therapeutic interventions.
Career Highlights
Nena Winand has established herself as a key figure in the field of cancer genetics. Her work at the Dana-Farber Cancer Institute Inc. has been instrumental in advancing our understanding of genetic markers associated with cancer.
Collaborations
Winand collaborates with Richard D. Kolodner, a fellow researcher who shares her passion for unraveling the complexities of cancer genetics.
Conclusion
Nena Winand's innovative research and patents contribute significantly to the field of cancer diagnostics and treatment. Her work continues to pave the way for advancements in understanding genetic predispositions to cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile